A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease

Autor: Lindsay H. M. Keir, Helen Harris, Stuart H. Ralston, Owen Cronin, Nikhil Hirani, Olivia McKnight

Publikováno v: Rheumatology International
Cronin, O, McKnight, O, Keir, L, Ralston, S H, Hirani, N & Harris, H 2021, ' A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease ', Rheumatology international, vol. 41, no. 5, pp. 921-928 . https://doi.org/10.1007/s00296-021-04835-1

Janus kinase inhibitors (JAKi) are an exciting option for the treatment of rheumatoid arthritis (RA) but little is known about their safety and tolerability in patients with existing respiratory disorders. The objective was to compare pulmonary safet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22be4cd814168bcc2674470d6044efbf
http://europepmc.org/articles/PMC8019418